New sudan ebola vaccine shows promise in phase 2 trial
⭐️ VACCINE ⭐️
Completed
This study tested a new vaccine designed to protect against Sudan ebolavirus, a close relative of the Ebola virus. Researchers gave the vaccine or a placebo to 125 healthy adults to see if it is safe and triggers an immune response. The goal is to find a way to prevent this deadl…
Phase: PHASE2 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:11 UTC